**Abstract**

**Objectives:** Molecular imaging with Positron Emission Tomography (PET) has been used to examine various aspects of dopaminergic transmission in schizophrenia and have converged to show excess striatal presynaptic release and activity, as well as functional supersensitivity of striatal D2 receptors. The striatal dysfucntion occurs early on in the course of the disease and predicts conversion to psychosis. More recently imaging studies have documented alterations in extrastriatal dopamine. We will present here the overall combined data from multiple studies done to date to extract a comprehensive topographical mapping of the dopaminergic dysfunction in schizophrenia and its complex relationship to clinical symptom domains.

**Methods:** PET imaging studies using D2/3 radiotracers combined with the amphetamine challenge in patients with schizophrenia and matched healthy controls to image striatal and extrastriatal capacity for dopamine release.

**Results:** Dopamine release is significantly reduced in patients with schizophrenia compared to controls matched for age, gender, ethnicity, smoking, parental socioeconomic status and catechol-O-methyltransferase (COMT) genotype in dorso-lateral prefrontal cortex (DLPFC) as well as in all cortical and in most extrastriatal regions. In particular the midbrain DA cell body region (i.e. substantia nigra and ventral tegmental area) showed a substantial blunting of release in drug-naïve and drug-free patients, compared to controls.

**Conclusions:** These observations of opposite presynaptic dopaminergic dysfunction between striatal and extrastriatal regions suggest that the striatal excess may not be driven by activity levels of midbrain DA cells but may result from abnormal striatal local regulation of presynaptic DA release, affecting specifically the associative striatum, region which shows largest magnitude of excess DA. Furthermore alterations in dopaminergic signaling in opposing directions may have a dual effect on learning across functional domains by weakening learning from salient or relevant signals and reinforcing stimulus independent signals, thus explaining different symptom domains.
